Nadia Waheed
Chief Tech/Sci/R&D Officer at OCULAR THERAPEUTIX, INC.
Net worth: 807 496 $ as of 2024-05-30
Profile
Nadia K.
Waheed is currently the Director at Bionic Sight LLC, the Director at Boston Image Reading Center LLC, and the Chief Medical Officer at Ocular Therapeutix, Inc. She previously worked as the Chief Medical Officer at Beacon Therapeutics (USA), Inc. and Gyroscope Therapeutics Holdings Plc.
She holds a graduate degree from Harvard T.H.
Chan School of Public Health and a doctorate degree from Aga Khan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OCULAR THERAPEUTIX INC
0.09% | 2024-05-31 | 141,666 ( 0.09% ) | 807 496 $ | 2024-05-30 |
Nadia Waheed active positions
| Companies | Position | Start |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Chief Tech/Sci/R&D Officer | 2024-05-19 |
| Boston Image Reading Center LLC | Director/Board Member | 2014-12-31 |
Bionic Sight LLC
 Bionic Sight LLC Pharmaceuticals: MajorHealth Technology Bionic Sight LLC develops neuro-prosthetic devices. The company was founded by Sheila Nirenberg on October 17, 2012 and is headquartered in New York, NY. | Director/Board Member | - |
Former positions of Nadia Waheed
| Companies | Position | End |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Chief Tech/Sci/R&D Officer | - |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | - |
Training of Nadia Waheed
| Harvard T.H. Chan School of Public Health | Graduate Degree |
| Aga Khan University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Bionic Sight LLC
Bionic Sight LLC Pharmaceuticals: MajorHealth Technology Bionic Sight LLC develops neuro-prosthetic devices. The company was founded by Sheila Nirenberg on October 17, 2012 and is headquartered in New York, NY. | Health Technology |
| Boston Image Reading Center LLC | |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Nadia Waheed
